ArticleBioinformatics (Oxford, England)2021
Prioritizing transcriptomic and epigenomic experiments using an optimization strategy that leverages imputed data.
Article in Bioinformatics (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
motivationSuccessful science often involves not only performing experiments well, but also choosing well among many possible experiments. In a hypothesis generation setting, choosing an experiment well means choosing an experiment whose results are interesting or novel. In this work, we formalize this selection procedure in the context of genomics and epigenomics data generation. Specifically, we consider the task faced by a scientific consortium such as the National Institutes of Health ENCODE Consortium, whose goal is to characterize all of the functional elements in the human genome. Given a list of possible cell types or tissue types ('biosamples') and a list of possible high-throughput sequencing assays, where at least one experiment has been performed in each biosample and for each assay, we ask 'Which experiments should ENCODE perform next?'
resultsWe demonstrate how to represent this task as a submodular optimization problem, where the goal is to choose a panel of experiments that maximize the facility location function. A key aspect of our approach is that we use imputed data, rather than experimental data, to directly answer the posed question. We find that, across several evaluations, our method chooses a panel of experiments that span a diversity of biochemical activity. Finally, we propose two modifications of the facility location function, including a novel submodular-supermodular function, that allow incorporation of domain knowledge or constraints into the optimization procedure. AVAILABILITY AND IMPLEMENTATION: Our method is available as a Python package at https://github.com/jmschrei/kiwano and can be installed using the command pip install kiwano. The source code used here and the similarity matrix can be found at http://doi.org/10.5281/zenodo.3708538. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.